| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
BCR/ABL1 by Quantitative RT-PCR: Minor (p190) : 1003716
Test CodeMDFCPBCRABLPMI or 1003716
Alias/See Also
Philadelphia Chromosome Ph1 Bone Marrow/Blood t(9;22) p190 detection.; BCR/ABL; BCR/ABL1; ALL
CPT Codes
81207
Instructions
Peripheral Blood in a lavender top tube (EDTA) or Bone Marrow in a lavender top tube (EDTA).
Transport Container
Submit 5 mL Blood (Min. 2 mL) or 2 mL Bone marrow (Min. 1 mL): Do not centrifuge.
Transport Temperature
Blood or Bone Marrow: Refrigerated.
Specimen Stability
Ambient: 1 hour; Refrigerated: 72 hours; Frozen: Unacceptable
Methodology
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Setup Schedule
Monday & Thursday
Report Available
2-5 days
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration
(FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
(FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
Reference Range
An interpretive report will be provided.
Clinical Significance
This test will detect the presence of BCR/ABL 1 minor (p190) fusion gene transcripts resulting from t(9;22) translocation in patients with CML, ALL, and AML. It is appropriate for use in monitoring the levels of BCR/ABL1 fusion transcript from patients with confirmed minor breakpoint Ph+ leukemia. A ratio of BCR/ABL1 minor transcript to reference gene will be reported. International scale (IS) reporting is not available for the minor transcript.
Performing Laboratory
med fusion
